Drug maker found liable despite FDA warning label

被引：0
|
作者：
机构：
来源：
Nature | 2009年 / 458卷 / 7235期
关键词：
D O I：
10.1038/458137c
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：137 / 137
相关论文
共 50 条
  • [31] FDA off-track on off-label drug promotion
    不详
    LANCET, 2007, 370 (9604): : 1976 - 1976
  • [32] Regulating off-label drug use - Rethinking the role of the FDA
    Stafford, Randall S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14): : 1427 - 1429
  • [33] Improved QSAR model for cholestasis built with FDA drug label data
    Girireddy, M.
    Saiakhov, R.
    Chakravarti, S.
    TOXICOLOGY LETTERS, 2021, 350 : S165 - S165
  • [34] Drug labeling: FDA requires new label for antibiotics to prevent overuse
    Tiwary, D
    JOURNAL OF LAW MEDICINE & ETHICS, 2003, 31 (03): : 458 - 460
  • [35] INDUSTRY ASKS FDA TO DITCH CHANGES TO DRUG-LABEL RULES
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, 93 (18) : 22 - 22
  • [36] Evaluation of FDA safety-related drug label changes in 2010
    Lester, Jean
    Neyarapally, George A.
    Lipowski, Earlene
    Graham, Cheryl Fossum
    Hall, Marni
    Dal Pan, Gerald
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (03) : 302 - 305
  • [37] FDA is criticised for poor oversight of drug companies' promotion of off-label drug use
    Tanne, Janice Hopkins
    BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7665):
  • [38] Off-Label Cancer Drug Compendia Found Outdated and Incomplete
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (16): : 1645 - 1646
  • [39] FDA may allow drug companies to promote "off-label" uses
    Tanne, Janice Hopkins
    BRITISH MEDICAL JOURNAL, 2007, 335 (7632): : 1229 - 1229
  • [40] Freedom of Speech and the FDA's Regulation of Off-Label Drug Uses
    Rogers, Jacob
    GEORGE WASHINGTON LAW REVIEW, 2008, 76 (05) : 1429 - 1443
12345